OM
Opaleye Management’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-75,000
| Closed | -$6.14M | – | 52 |
|
|
2024
Q4 | $6.14M | Sell |
75,000
-10,000
| -12% | -$819K | 1.07% | 20 |
|
|
2024
Q3 | $9.71M | Hold |
85,000
| – | – | 1.62% | 14 |
|
|
2024
Q2 | $6.42M | Hold |
85,000
| – | – | 1.47% | 22 |
|
|
2024
Q1 | $5.81M | Sell |
85,000
-5,000
| -6% | -$342K | 1.27% | 26 |
|
|
2023
Q4 | $5.65M | Hold |
90,000
| – | – | 1.5% | 19 |
|
|
2023
Q3 | $4.59M | Sell |
90,000
-87,000
| -49% | -$4.44M | 1.49% | 17 |
|
|
2023
Q2 | $8.84M | Hold |
177,000
| – | – | 2.11% | 11 |
|
|
2023
Q1 | $6.63M | Hold |
177,000
| – | – | 1.99% | 14 |
|
|
2022
Q4 | $8.49M | Sell |
177,000
-13,000
| -7% | -$623K | 2.95% | 8 |
|
|
2022
Q3 | $4.56M | Hold |
190,000
| – | – | 1.88% | 18 |
|
|
2022
Q2 | $4.13M | Sell |
190,000
-21,000
| -10% | -$457K | 1.86% | 18 |
|
|
2022
Q1 | $5.1M | Sell |
211,000
-104,800
| -33% | -$2.53M | 1.58% | 21 |
|
|
2021
Q4 | $7.51M | Sell |
315,800
-37,600
| -11% | -$895K | 1.59% | 23 |
|
|
2021
Q3 | $8.97M | Sell |
353,400
-4,400
| -1% | -$112K | 1.67% | 20 |
|
|
2021
Q2 | $8.05M | Hold |
357,800
| – | – | 1.34% | 25 |
|
|
2021
Q1 | $7.07M | Buy |
357,800
+22,600
| +7% | +$446K | 1.04% | 30 |
|
|
2020
Q4 | $8.91M | Buy |
335,200
+22,200
| +7% | +$590K | 1.16% | 25 |
|
|
2020
Q3 | $15.5M | Buy |
+313,000
| New | +$15.5M | 3.02% | 11 |
|